331 related articles for article (PubMed ID: 36439976)
1. Pyrazole-containing pharmaceuticals: target, pharmacological activity, and their SAR studies.
Li G; Cheng Y; Han C; Song C; Huang N; Du Y
RSC Med Chem; 2022 Nov; 13(11):1300-1321. PubMed ID: 36439976
[TBL] [Abstract][Full Text] [Related]
2. Overview of recent developments of pyrazole derivatives as an anticancer agent in different cell line.
Bennani FE; Doudach L; Cherrah Y; Ramli Y; Karrouchi K; Ansar M; Faouzi MEA
Bioorg Chem; 2020 Apr; 97():103470. PubMed ID: 32120072
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and Pharmacological Activities of Pyrazole Derivatives: A Review.
Karrouchi K; Radi S; Ramli Y; Taoufik J; Mabkhot YN; Al-Aizari FA; Ansar M
Molecules; 2018 Jan; 23(1):. PubMed ID: 29329257
[TBL] [Abstract][Full Text] [Related]
4. Pyrazole; A Privileged Scaffold of Medicinal Chemistry: A Comprehensive Review.
Kumar R; Sharma R; Sharma DK
Curr Top Med Chem; 2023; 23(22):2097-2115. PubMed ID: 37455456
[TBL] [Abstract][Full Text] [Related]
5. Indole-containing pharmaceuticals: targets, pharmacological activities, and SAR studies.
Zeng W; Han C; Mohammed S; Li S; Song Y; Sun F; Du Y
RSC Med Chem; 2024 Mar; 15(3):788-808. PubMed ID: 38516587
[TBL] [Abstract][Full Text] [Related]
6. Recently reported biological activities of pyrazole compounds.
Faria JV; Vegi PF; Miguita AGC; Dos Santos MS; Boechat N; Bernardino AMR
Bioorg Med Chem; 2017 Nov; 25(21):5891-5903. PubMed ID: 28988624
[TBL] [Abstract][Full Text] [Related]
7. The therapeutic voyage of pyrazole and its analogs: A review.
Khan MF; Alam MM; Verma G; Akhtar W; Akhter M; Shaquiquzzaman M
Eur J Med Chem; 2016 Sep; 120():170-201. PubMed ID: 27191614
[TBL] [Abstract][Full Text] [Related]
8. Heterocycles in Breast Cancer Treatment: The Use of Pyrazole Derivatives.
Ardevines S; Marqués-López E; Herrera RP
Curr Med Chem; 2023; 30(10):1145-1174. PubMed ID: 36043746
[TBL] [Abstract][Full Text] [Related]
9. Diverse Pharmacological Potential of different Substituted Pyrazole Derivatives.
Asif M; M Almehmadi M; Alsaiari A; Allahyani M
Curr Org Synth; 2023 Oct; ():. PubMed ID: 37861007
[TBL] [Abstract][Full Text] [Related]
10. Pyrazole Scaffolds Having Promising Pharmacological Potential: A Review.
Singh S; Tehlan S; Kumar Verma P
Mini Rev Med Chem; 2023; 23(22):2142-2165. PubMed ID: 36959145
[TBL] [Abstract][Full Text] [Related]
11. Nitrile-containing pharmaceuticals: target, mechanism of action, and their SAR studies.
Wang X; Wang Y; Li X; Yu Z; Song C; Du Y
RSC Med Chem; 2021 Oct; 12(10):1650-1671. PubMed ID: 34778767
[TBL] [Abstract][Full Text] [Related]
12. Pyrazole Containing Anti-HIV Agents: An Update.
Kumar S; Gupta S; Rani V; Sharma P
Med Chem; 2022; 18(8):831-846. PubMed ID: 34994333
[TBL] [Abstract][Full Text] [Related]
13. Nitrogen Containing Heterocycles as Anticancer Agents: A Medicinal Chemistry Perspective.
Kumar A; Singh AK; Singh H; Vijayan V; Kumar D; Naik J; Thareja S; Yadav JP; Pathak P; Grishina M; Verma A; Khalilullah H; Jaremko M; Emwas AH; Kumar P
Pharmaceuticals (Basel); 2023 Feb; 16(2):. PubMed ID: 37259442
[TBL] [Abstract][Full Text] [Related]
14. Recent advanced in bioactive systems containing pyrazole fused with a five membered heterocycle.
Raffa D; Maggio B; Raimondi MV; Cascioferro S; Plescia F; Cancemi G; Daidone G
Eur J Med Chem; 2015 Jun; 97():732-46. PubMed ID: 25549911
[TBL] [Abstract][Full Text] [Related]
15. Current scenario of pyrazole hybrids with in vivo therapeutic potential against cancers.
Xu Z; Zhuang Y; Chen Q
Eur J Med Chem; 2023 Sep; 257():115495. PubMed ID: 37209450
[TBL] [Abstract][Full Text] [Related]
16. Recent Advancement in Drug Design and Discovery of Pyrazole Biomolecules as Cancer and Inflammation Therapeutics.
Alam MJ; Alam O; Naim MJ; Nawaz F; Manaithiya A; Imran M; Thabet HK; Alshehri S; Ghoneim MM; Alam P; Shakeel F
Molecules; 2022 Dec; 27(24):. PubMed ID: 36557840
[TBL] [Abstract][Full Text] [Related]
17. Pyrazole (1, 2-diazole) induce apoptosis in lymphoma cells by targeting BCL-2 and BCL-XL genes and mitigate murine solid tumour development by regulating cyclin-D1 and Ki-67 expression.
Vishnu WK; Abeesh P; Guruvayoorappan C
Toxicol Appl Pharmacol; 2021 May; 418():115491. PubMed ID: 33737021
[TBL] [Abstract][Full Text] [Related]
18. Discovery of Anticancer Agents from 2-Pyrazoline-Based Compounds.
Li QS; Shen BN; Zhang Z; Luo S; Ruan BF
Curr Med Chem; 2021; 28(5):940-962. PubMed ID: 32141413
[TBL] [Abstract][Full Text] [Related]
19. Recent Advancement of Pyrazole Scaffold Based Neuroprotective Agents: A Review.
Das S; Akbar S; Ahmed B; Dewangan RP; Iqubal MK; Iqubal A; Chawla P; Pottoo FH; Joseph A
CNS Neurol Disord Drug Targets; 2022; 21(10):940-951. PubMed ID: 34080970
[TBL] [Abstract][Full Text] [Related]
20. Recent advances in bioactive pyrazoles.
Küçükgüzel ŞG; Şenkardeş S
Eur J Med Chem; 2015 Jun; 97():786-815. PubMed ID: 25555743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
